That regulatory distinction matters for trust, medical accuracy, and patient expectations
Dushay cited hopes that pill versions of GLP-1 drugs could ease shortages, come at lower cost and enhance convenience
GLP-1 agonists primarily influence insulin and satiety, while GIP (glucose-dependent insulinotropic polypeptide) affects fat metabolism
Future research is extremely necessary to determine more evidence-based preoperative guidelines for these patients to mitigate risks
NHS England rolled out tirzepatide for weight management in cohorts after NICE TA1026 in December 2024: 3 Cohort 1 (from June 2025): adults with a body mass index (BMI) of 40 or higher and at least four of five weight-related conditions (type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease)
I cant say that it made a big difference, although I did notice some new baby-fine hairs along my hairline